GPR39 deficiency may abolish these monoaminergic-based antidepressant effects since GPR39 KO mice do respond to treatment with the selective serotonin reuptake inhibitor (SSRI), escitalopram, in a forced-swim depression assay [61,102]. Here, GPR39 is linked to major depressive disorder.